Article

jdsupra.com on 2023-05-04 20:12

Life Sciences: What's new in France? A legal update on recent developments in the life sciences sector

The Administrative Supreme Court upholds decisions restricting the prescription of a treatment against osteoporosis. Upon the ...

Related news

Special Report: Developments in UK Life Sciences – Spring Update 2022 jdsupra.com
United Kingdom
Recent Regulatory Developments in the Mexican Power Sector jdsupra.com
United States , China , Japan , France , Spain
EU – Parallel trade in the life sciences sector – Q&A jdsupra.com
Sia , Spain , France , Art 101 , Belgium
Brexit's impact on energy sector remains uncertain despite recent parliamentary and legal developments jdsupra.com
United Kingdom
Recent Regulatory Developments in the Mexican Power Sector—Chapter 2: The Tug of War Continues jdsupra.com
Amparo , Spain , Tamaulipas , Colima , Jalisco
The Impact of the New EU AI Act on the Medtech and Life Sciences Sector jdsupra.com
United Kingdom , Europe
UK Life Sciences and Healthcare Newsletter: Life Sciences - What's new in France? Foreign direct investment control in France in time of COVID jdsupra.com
France
UK Life Sciences and Healthcare Newsletter: Life Sciences: What's new in France? The new French anti-gift regulation is live since 1st October 2020 jdsupra.com
France
UK Life Sciences and Healthcare Newsletter: Life Sciences - What's new in France? Decree of 25 August 2020 on the harmonization of market access conditions: will simplification benefit stakeholders?jdsupra.com
France
In Washington’s life sciences sector, a streak of companies going public Seattle Times
United Kingdom , Cambridge , Bothell , San Francisco , San Francisco Bay Area
Dundee’s world-class life sciences sector praised by city council leader The Daily Record
Europe
Life Sciences Sector Vision jdsupra.com
San Francisco
CFIUS: Recent Developments and Trends jdsupra.com
Washington , Russia , France , Canada , Australia
What is the Impact of Recent Regulation and Government Measures on Investments in Healthcare and Life Sciences in Europe?jdsupra.com
Germany , Europe
Recent Developments in Data Privacy jdsupra.com
Schrems , Safe Harbor , United States , Europe
European Life Sciences Deals Trends jdsupra.com
France , Germany , Europe
[Ongoing Program] Life Sciences Session: Pharma Brands v. Generics: Developments Affecting the Balance Between Exclusivity and Market Entry - March 2nd, 10:00 am - 11:00 am JST jdsupra.com
Orange , United Kingdom , Japan
Digital Platform Workers in Europe - Recent Developments jdsupra.com
Milan , Paris , Spain , Netherlands , Italy
UK Life Sciences and Healthcare Newsletter: Life Sciences: What's new in France? The Santen case and the notion of second medical use with regards to supplementary protection certificates (SPC): a strict interpretation of the EU regulation jdsupra.com
Paris , France
UK Life Sciences and Healthcare Newsletter: Life Sciences: What's new in France? Avastin/Lucentis case: French Competition Authority imposes record fine of 444 million euros on Novartis and Roche for alleged abuse of collective dominant position jdsupra.com
Italy , United States , France